Company / Debt per Share
Adaptive Biotechnologies Corp Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.86
FY2025
5-year range
$0.86 / $0.91
FY2022-FY2025
Trend
-6.2%
vs FY2024
Sector context
#63 of 82
Health Care
What the data says
Adaptive Biotechnologies Corp's debt per share of $0.86 is lower than 77% of companies in the Health Care sector (FY2025). Debt per Share remained relatively stable over the past 4 years, with values between $0.86 and $0.91.
Based on SEC 10-K filings.
0.86 in FY2025 with a 3-year CAGR of -1.1%.
Improved from $0.91 to $0.86 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 82This company $0.86 Sector average $126.59
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 6.2% year-over-year.
- Ranks #63 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.86 | -6.2% |
| FY2024 | $0.91 | -0.0% |
| FY2023 | $0.91 | +3.0% |
| FY2022 | $0.89 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026